ASP Isotopes Inc (ASPI) Stock Analysis

Verdict: AVOID

Commercial progress in isotope supply and helium production is overshadowed by massive operating cash burn and heavy insider selling.

Investment score: 26/100

Analysis as of

Is ASP Isotopes Inc stock worth reviewing? The TradeMates thesis

The TradeMates model evaluates ASP Isotopes (ASPI) as an AVOID. Despite strong revenue growth driven by acquisitions and partnerships, deep operating losses and massive dilution/debt burdens make the risk/reward profile unfavorable.

7-factor investment score

ASP Isotopes Inc opportunities and risks

What speaks for ASPI

What speaks against ASPI

Peers and competitors

Trailing-twelve-month ratios
TickerP/EP/SEV/EBITDAGross marginNet marginFCF yield
ASPIn/a11.0xn/a18.3%-428.0%-24.7%
ECVTn/a1.3x9.8x21.0%-7.1%6.5%
FTK23.2x3.1x18.5x24.5%13.0%-0.6%
RYAMn/a0.3x7.8x5.9%-9.6%-7.7%
ASPNn/a2.2xn/a2.7%-62.4%8.4%
VHIn/a0.2x7.9x14.7%-1.8%15.1%
Peer mediann/a1.3x7.9x14.7%-7.1%6.5%

Frequently asked questions about ASP Isotopes Inc (ASPI)

Is ASPI stock a good investment?

The TradeMates model rates ASP Isotopes Inc as AVOID with an investment score of 26/100. The TradeMates model evaluates ASP Isotopes (ASPI) as an AVOID. Despite strong revenue growth driven by acquisitions and partnerships, deep operating losses and massive dilution/debt burdens make the risk/reward profile unfavorable. This is algorithmic model output, not personal investment advice.

Is ASPI stock a buy?

The TradeMates model verdict for ASPI is AVOID with an investment score of 26/100. Treat this as a model signal to review, not a personal buy recommendation.